Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria  by Dohrman, Austin et al.
 .Biochimica et Biophysica Acta 1406 1998 251–259
 /Mucin gene MUC 2 and MUC 5AC upregulation by Gram-positive and
Gram-negative bacteria
Austin Dohrman a,d, Susumu Miyata a, Marianne Gallup a, Jian-Dong Li a,
Catherine Chapelin e, Andre Coste e, Estelle Escudier e, Jay Nadel b,c,d, Carol Basbaum a,d,)
a Department of Anatomy, Uni˝ersity of California San Francisco, San Francisco CA 94143, USA
b Department of Physiology, Uni˝ersity of California San Francisco, San Francisco, CA 94143, USA
c Department of Medicine, Uni˝ersity of California San Francisco, San Francisco, CA 94143, USA
d Cardio˝ascular Research Institute, Uni˝ersity of California San Francisco, San Francisco CA 94143, USA
e Uni˝ersite de Paris, Faculte de Medecine de Creteil, Department d’Histologie, Paris, France
Received 8 December 1997; accepted 30 January 1998
Abstract
Bacterial infection of the lung is associated with mucin overproduction. In partial explanation of this phenomenon, we
 .recently reported that supernatant from the Gram-negative organism Pseudomonas P. aeruginosa contained an activity
wthat upregulated transcription of the MUC 2 mucin gene J.-D. Li, A. Dohrman, M. Gallup, S. Miyata, J. Gum, Y. Kim, J.
Nadel, A. Prince, C. Basbaum, Transcriptional activation of mucin by P. aeruginosa lipopolysaccharide in the pathogenesis
 . xof cystic fibrosis lung disease, Proc. Natl. Acad. Sci. U.S.A., 94 1997 967–972 . The purpose of the present study was to
determine whether mucin genes other than MUC 2 are so regulated and whether Gram-positive organisms also contain
mucin stimulatory activity. Results from in situ hybridization and RNase protection assays showed that P. aeruginosa
upregulates MUC 5AC as well as MUC 2 in both bronchial explants and cultured airway epithelial cells. The upregulation
 .of both genes by P. aeruginosa can be mimicked by lipopolysaccharide LPS and can be blocked by the tyrosine kinase
inhibitor genistein. In addition, both genes are upregulated by a variety of Gram-positive as well as Gram-negative
organisms showing the same rank order of potency. These data indicate the existence of a general mechanism by which
epithelial cells respond to the presence of bacteria by increasing mucin synthesis. q 1998 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Mucin overproduction exacerbates bacterial pneu-
 .monia and cystic fibrosis CF lung disease. Recently
) Corresponding author. Tel.: q1-415-476-3835; fax: q1-415-
476-4845; E-mail: cbas@itsa.ucsf.edu
we observed by in situ hybridization that MUC 2, a
w xgene cloned from the intestine 1 and generally
w xexpressed weakly in the airways 2 , is expressed
w xstrongly in CF airways 3 . We determined that a
factor contributing to this upregulation was the com-
w xmon CF pathogen P. aeruginosa 3 . We wondered
whether the phenomenon was specific to P. aerugi-
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nosa and the MUC 2 gene or might extend to other
bacteria and mucin genes as well. If the phenomenon
is a general one, are the regulatory mechanisms the
same or different for each mucin gene MUC 1, 3–8
w x ..1,4–10 12 and bacterium? Answers to these ques-
tions could lead to therapeutic approaches for block-
ing bacterially-induced mucin overproduction.
To this end, we examined the bacterial inducibility
of the mucin gene MUC 5AC, which shows relatively
high levels of expression even in healthy human
w xairways 2 and has been found to show an altered
w xtissue distribution in CF airways 11 . We found that
it too is upregulated by P. aeruginosa and that the
regulatory mechanisms share similarities with those
previously described for MUC 2. In addition, we
found that both MUC 2 and MUC 5AC are inducible
by supernatants from a wide variety of Gram-nega-
tive and Gram-positive bacteria. The generality of the
phenomena observed so far offers promise that a
single class of inhibitors aimed at an epithelial cell
signaling molecule may eventually control mucus
hypersecretion induced by both Gram-negative and
Gram-positive organisms.
2. Methods
2.1. Tissue procurement and preser˝ation for in situ
hybridization
To determine whether MUC 5AC, like MUC 2 is
upregulated in CF airways, we examined human nasal
polyps as well as bronchial samples from donors and
recipients at the time of lung transplantation. All
tissue types were removed and processed according
to UCSF policy and were directly fixed or placed in
vitro and exposed to P. aeruginosa as described
below. Tissue samples were fixed in 4% paraformal-
dehyder0.1 M phosphate buffer for 4 h and cryopro-
tected in 30% sucroser0.1 M phosphate buffer
overnight at 48C. The next day, samples were embed-
 .ded in OCT compound Miles, Elkhart, IN and
quickly frozen in liquid nitrogen-cooled Freon-22.
 .The frozen tissue was sectioned 6 mm , placed on
Superfrost Plus slides Fisher Scientific, Pittsburgh,
.PA and air dried quickly. The sections were stored at
y808C until use.
2.2. Human bronchial explant cultures
Segmental to subsegmental bronchi from lung
donors and recipients were sectioned to yield
bronchial rings 0.5 mm in length. These were rinsed
in sterile PBS before incubation in a serum-free, 1:1
 .mixture of Dulbecco’s modified Eagle’s DME and
 .Ham’s F-12 F12 supplemented with penicillin,
streptomycin, gentamycin and amphotericin B.
2.3. Human airway epithelial cell cultures
NCI H292 cells were grown in RPMI 1640q10%
FCS. Medium was changed every 3 days. Incubation
with P. aeruginosa supernatant was at 3 days post
confluence.
2.4. Bacterial culture and preparation of cell-free
supernatants
P. aeruginosa strain PAO1 was grown in M9
w x  .buffer 12 for 72 h at 378C to late log phase . All
other bacterial strains were grown to late log phase in
LB buffer. Cell-free supernatant was obtained by
centrifugation at 10,000 rpm for 60 min at 48C and
 .by filtration through a 0.22 mm filter Corning .
Supernatant was aliquoted and stored at y808C until
used.
2.5. Exposure of tissues and cells to bacterial cell-free
filtrates
w xIncubation was as described in Ref. 13 . Briefly,
cells or organ culture specimens were washed twice
with PBS at 378C. Samples were then incubated with
 .bacterial supernatant or buffer M9 or LB diluted 1:4
with RPMI 1640 for 6 h. Total RNA was obtained
w xfrom pelleted cells scraped from the culture dish 14 .
Lactic dehydrogenase release was measured LDH
.320, Sigma to detect any cell lysis.
2.6. RNA probes
A single MUC 5AC cRNA probe was used for
both in situ hybridization and RNase protection assay
 .RPA . This probe was constructed using PCR with
primers corresponding to nucleotides 580–604 and
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w x851–875 of the cDNA sequence described in Ref. 9 .
The resulting 295 bp cDNA was TA-cloned into
 .pCRII vector Invitrogen, San Diego, CA . The MUC
2 probe for RPA was constructed using PCR with
primers corresponding to nucleotides 423 to 639 of
w xthe cDNA sequence described in Ref. 15 . The re-
sulting 216 bp cDNA was TA-cloned into pCRII
 .vector Invitrogen . The MUC 2 probe for in situ
hybridization was generated from the 90 bp HAM 1
w x insert 16 in pBluescript plasmid Stratagene, La
. w32 x w35 xJolla, Ca . P or S UTP-labeled RNA probes
were synthesized from the cDNA in linearized pBlue-
script or pCRII plasmid using T7, T3, or SP6 poly-
merases. Antisense and sense probes were used at
concentrations of 2–5=105 cpmrml. The linearized
template for the housekeeping gene cyclophilin was
purchased from Ambion. The pTRI-cyclophilin–hu-
man anti-sense control contains a 103 bp cDNA
insert of a highly conserved region of the human
cyclophilin gene spanning exons 1 and 2 nucleotides
.38–140 of Accessiona X52856 . The probe was
w32 xprepared as above using P UTP and T7 poly-
merase according to manufacturer’s instructions.
2.7. In situ hybridization
Frozen sections of human nasal polyp or bronchus
were air dried quickly, heated at 558C for 10 min,
fixed with 4% paraformaldehyde in PBS for 10 min,
washed with 2= SSC 0.3 M NaClr0.03 M sodium
.citrate, pH 7.0 , immersed in 0.1 M triethanolamine
 .HCl pH 7.5 containing 0.25% acetic anhydride for
10 min, rinsed with 2= SSC, dehydrated with ethanol
and air dried. RNA probes described above were
applied in a hybridization mixture containing deion-
 .  .ized formamide 50% , dextran sulfate 10% , tRNA
 .   ..0.5 mgrml , Ficoll 400 0.02% wrv , salmon
 . sperm DNA 1 mgrml , polyvinylpyrrolidone 0.02%
 ..wrv , 10 mM DTT, 0.3 M NaCl, 0.5 mM EDTA,
 .10 mM Tris–HCL, and 10 mM NaPO pH 6.8 . The4
mixture was heated to 708C for 15 min and chilled on
ice. Fresh DTT was added to achieve a concentration
of 20 mM. Then 100 ml of the mixture was applied
to each section and parafilm coverslips were applied.
Hybridization was carried out in humid chambers
overnight at 558C. Coverslips were removed in 5=
SSC, 10 mM DTT, at 558C. Sections were washed
three times in wash buffer 2= SSC, 1 mM EDTA,
 ..10 mM b-mercaptoethanol b ME for 5 min at
room temperature. Subsequently, they were treated
with 20 mgrml of RNase A in 500 mM NaCl, 10
 .mM Tris pH 8.0 for 30 min at room temperature.
This was followed by 2=5 min changes of wash
buffer and a high stringency wash in 4 l of a wash
solution containing 0.1= SSC, 1 mM EDTA and 10
 .mM b ME 2 h at 558C . Slides were then washed 5
min at room temperature in 0.5= SSC without b ME
and EDTA. Finally, sections were dehydrated with
ethanol and air-dried. The slides were exposed to
Ilford K5D emulsion, and stored in the dark at 48C
until developed after 3–10 days exposure.
2.8. Imaging and quantification
We used NIH Image software. Because polyp
epithelium is irregular in shape, we evaluated in situ
hybridization labeling density by obtaining a series of
brightness measurements for areas of epithelium at
fixed intervals and averaging them. We analyzed four
slides of nasal polyps from nine CF and 11 non-CF
individuals in this way. In bronchial explants, the
epithelium consisted of rectangular areas in each
cross section. We established brightness thresholds
and collected binary image data consisting of total
pixels per unit length of epithelium in four slides
each for three CF and three non-CF subjects. For the
P. aeruginosa explant incubation study, we analyzed
four slides of airway epithelium from treated and four
from untreated explants in two separate studies based
on two individual lung donor subjects.
2.9. RNase protection assay
MUC 2 and MUC 5AC cDNA inserts were gener-
ated by PCR as described above and subcloned into
TA vector. The vector was linearized with BamHI in
a 100 ml vol at 378C overnight. The DNA was
digested with Proteinase K before extracting with
equal volumes of phenolrchloroformrisoamyl alco-
hol. The extract was precipitated with ammonium
acetate and ethanol for 15 min at y808C and redis-
solved in DEPC water. Riboprobe was synthesized in
the presence of 32P-labeled UTP using linearized and
purified DNA template. Then it was subjected to
RNase-free DNase I at 378C, phenol-extracted and
ethanol-precipitated. The pellet was resuspended in
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 .  .Fig. 1. In situ hybridization analysis of nasal polyp epithelium from non-CF A and CF B subjects showing considerably more MUC
5AC mRNA in the CF than the non-CF sample. Both were probed with an 35S labeled MUC 5AC probe containing non-repetitive
sequence.
 .  .  .Fig. 2. In situ hybridization analysis of bronchial epithelium from non-CF A and C and CF B and D subjects. Epithelium epith. and
 .submucosal glands submuc. glands are different fields from the same tissue sections. Samples were probed as above.
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Fig. 3. Morphometric analysis of MUC 5AC mRNA autoradio-
graphic grain density in nasal polyps and bronchial explants of
CF and non-CF subjects. Nasal polyps were taken from 11
non-CF and nine CF subjects; bronchial explants were taken from
three non-CF and three CF subjects.
gel loading buffer. The probe was purified on a
polyacrylamiderurea gel kept at 300 V for 1 h. The
target band on the gel was visualized by exposing the
gel to film for 15 s. The band was excised and
 .incubated in elution buffer RPA II kit, Ambion at
378C overnight.
Experimental RNA samples were precipitated and
dissolved in hybridization buffer. A total of 10 ml of
probe was added, the samples were heated and al-
lowed to hybridize overnight. After hybridization,
 .RNase A and T RPAII kit, Ambion were added to
each sample and incubated at 378C for 30 min. The
samples were precipitated, redissolved in gel loading
buffer, denatured at 958C, and run on a standard
30=38 cm, 6% polyacrylamider8 M urea sequenc-
ing gel at 250 V for 1–2 h. The gel was dried and
placed on film at y808C for 2–7 days.
Fig. 4. In situ hybridization analysis of MUC 5AC mRNA in bronchial explants from a lung donor. Explants were exposed to P.
 .  .aeruginosa supernatant P. aer. or M9 buffer control for 6 h as described in Section 2. epithssurface epithelium; submuc.
glandsssubmucosal glands.
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Fig. 5. Morphometric analysis of MUC 5AC mRNA autoradio-
graphic grain density in bronchial explants that had been treated
 .  .with P. aeruginosa P. aer. or M9 buffer control as described
in legend for Fig. 4. Data from experiments 1 and 2 are shown.
2.10. ELISA to detect mucin glycoprotein released
by epithelial cells in presence and absence of
P. aeruginosa exposure
w xELISA was performed as previously described 17 .
Briefly, antigen diluted in 0.05 M sodium bicarbonate
was dried down overnight at 378C onto 96 well plates
 .Immulon 2, Dynatech . After blocking with phos-
phate-buffered saline containing 0.3% triton and 1%
normal goat serum, plates were incubated with anti-
w xhuman mucin monoclonal antibody 10G5 17 diluted
1:10 for 1 h at room temperature. Antigen–antibody
binding was detected using the Vectastain ABC-AP
 .kit Vector Labs with p-nitrophenyl phosphate as
substrate.
3. Results
In situ hybridization revealed that MUC 5AC
 .mRNA levels are elevated in CF nasal polyps Fig. 1
 .and bronchi Fig. 2 with respect to analagous sam-
ples from non-CF subjects. As previously reported
w xfor MUC 2 3 , both surface epithelium and submu-
cosal glands showed MUC 5AC upregulation. MUC
5AC mRNA occupied more of the linear surface of
CF than non-CF mucosal epithelium and was more
abundant on a per cell basis. Quantification of autora-
 .diographic grain density confirmed this Fig. 3 .
P. aeruginosa is a common pathogen in CF air-
ways. To examine the possibility that it participates
in upregulation of MUC 5AC, we exposed bronchial
explants from two individual lung donors to P.
aeruginosa supernatants for 6 h in vitro and then
examined them by in situ hybridization. We observed
increased MUC 5AC expression in both surface ep-
 .ithelium and submucosal glands Fig. 4 . Morphome-
tric analysis for two separate experiments is shown in
Fig. 5.
Due to the cellular complexity of human bronchial
explants, it was unclear from these experiments
whether P. aeruginosa supernatant was acting di-
rectly on epithelial cells or through resident inflam-
matory cells to upregulate MUC 5AC. To investigate
this, we tested the ability of P. aeruginosa to upregu-
late MUC 5AC in human bronchial epithelial cell
 .NCI H292 cultures lacking inflammatory cells.
 .  .Fig. 6. RNase protection assay showing that both P. aeruginosa supernatant P. aer. and LPS 10 mgrml strongly and directly
 .upregulate steady state levels of MUC 5AC mRNA in cultured airway epithelial cells NCI H292 . Serum has a weak stimulatory effect.
 .Compare with MUC 5AC signals from cells incubated in serum-free medium SFM . Cyclophilin mRNA levels are monitored to assess
the amount RNA used in each hybridization reaction.
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Fig. 7. ELISA data showing a greater abundance of mucin
immunoreactive material in supernatants from NCI H292 epithe-
 .lial cells exposed to P. aeruginosa P. aer. than in supernatants
 .from cells incubated in serum-free medium SFM or P. aerugi-
 .nosa growth medium PGM ; mean"s.e.m., Ns4.
 .Fig. 6 shows RNase protection assay RPA data
indicating that these epithelial cells responded to P.
aeruginosa and to P. aeruginosa LPS by greatly
increasing their pools of steady state MUC 5AC
mRNA. It can be seen from these data that serum,
added as a source of LPS binding protein, has a
relatively weak stimulatory effect on MUC 5AC when
used alone. The P. aeruginosa-induced increase in
MUC 5AC mRNA is accompanied by an increase in
mucin glycoprotein as shown by ELISA analysis
 .  .Fig. 7 . Sensitivity to inhibition by genistein Fig. 8
indicates that the mucin upregulation response is
dependent on tyrosine phosphorylation.
Fig. 8. RNase protection assay showing that the tyrosine kinase
 .inhibitor genistein Gen inhibits the P. aeruginosa induction of
 .MUC 5AC in cultured airway epithelial cells NCI H292 . SFM
sserum-free medium, P. aer.s P. aeruginosa supernatant.
Fig. 9. RNase protection assay showing the effects of various
bacterial supernatants on MUC 2 and MUC 5AC steady state
 .mRNA levels in airway epithelial cells NCI H292 . Lane 1:
serum-free medium; lane 2: P. aeruginosa; lane 3: E. coli; lane
4: S. aureus; lane 5: S. epidermidis; lane 6: Str. pyogenes.
To determine whether Gram-positive as well as
Gram-negative bacteria are capable of mucin upregu-
lation, we exposed epithelial cells to the Gram-nega-
tive bacteria P. aeruginosa and E. coli as well as to
the Gram-positive bacteria Staphylococcus aureus, S.
epidermidis and Streptococcus pyogenes. As shown
in Fig. 9, all bacteria tested were capable of upregu-
lating both MUC 2 and MUC 5AC, but to varying
degrees. That the rank order potency for MUC 2 is
similar to that for MUC 5AC suggests that common
mechanisms operate with respect to both genes.
4. Discussion
Bacterial infection of the airways is often accom-
panied by mucin overproduction, a phenomenon that
can lead to airflow obstruction, respiratory insuffi-
ciency, and secondary infection. The link between
infection and mucin overproduction is poorly under-
stood. Recently we found that P. aeruginosa culture
supernatant stimulates transcription of the MUC 2
w xmucin gene 3 . As MUC 2 is only one of nine
 wknown human mucin genes MUC 1, 3–8 1,4–
x ..10 12 and P. aeruginosa is only one of many
bacterial pathogens, we wondered whether the effect
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of P. aeruginosa on MUC 2 might be a specific
example of a general phenomenon whereby epithelial
cells respond to bacteria by coordinately activating
the expression of several mucin genes.
Our data provide evidence favoring this possibility
in showing that P. aeruginosa acts on airway epithe-
lial cells to activate not only MUC 2 but also MUC
w x5AC 5,9,18 . Furthermore, both genes are upregu-
lated by a variety of Gram-positive and Gram-nega-
tive bacteria.
Our initial observations were made on nasal polyps
excised therapeutically from CF and non-CF subjects.
Polyps are intrinsically complex, reactive structures,
containing inflammatory cells and mediators. The
presence of ongoing inflammatory reactions in both
CF and non-CF polyps may explain the relatively
high levels of MUC 2 and MUC 5AC RNA seen
there, as the inflammatory mediator TNF a is known
w xto activate mucin transcription 19 . Despite an over-
all high level of MUC 5AC expression in the polyps,
we detected more MUC 5AC mRNA in the CF than
in the non-CF polyps and subsequently reproduced
this finding in CF vs. non-CF bronchi.
Our detection of elevated mucin mRNA levels in
CF airways by in situ hybridization supports earlier
histopathological and pulse-labeling studies suggest-
ing that mucin synthesis is upregulated in CF airways
w x w x20 21 . Our data extend the earlier observations by
suggesting that an important stimulus for mucin syn-
thesis in CF airways is the common CF pathogen P.
aeruginosa. Not only does this pathogen upregulate
mucin mRNA, but it also upregulates mucin protein
as shown in Fig. 7. That the fold increase in mucin
protein is smaller than the fold increase in MUC 2
and MUC 5AC mRNA may be due to the fact that
the antibody-based mucin assay collectively monitors
the contributions of nine or more mucin genes, not all
of which may require P. aeruginosa for high level
expression, contributing to a relatively high baseline.
Components of P. aeruginosa that could mediate
MUC 2 and MUC 5AC upregulation include a vari-
ety of proteases including elastase and alkaline pro-
w x w x  . w xteinase 22 23 , exotoxin A 20 , exoenzyme S 24 ,
w x w xrhamnolipids 25 hydrocyanic acid 24 , phenazine
 .  .pigments 23 , leukocidin 24 , Pseudomonas autoin-
w xducer, a -1 kD component that induces IL-8 13
 . w xand endotoxin LPS 26 . Based on our in vivo
studies showing mucin induction in rat airways by
w xLPS 27 , we administered LPS to isolated cultures of
epithelial cells and obtained evidence supporting the
existence of a direct effect of LPS on epithelial cells
w x .3 and the present data .
That the effect of P. aeruginosa on MUC 2 was
at least partly at the level of transcription was clear
from transient transfection assays with a MUC 2
w xluciferase reporter gene 3 . Our recent cloning of the
MUC 5AC promoter permitted parallel studies in
which we observed that MUC 5AC transcription is
w xalso responsive to P. aeruginosa 28 . It will be
informative to compare response elements and tran-
scription factors involved in each gene’s response to
various bacteria. How, for example, do responses to
Gram-positive organisms, which lack LPS, differ from
responses to Gram-negative organisms? Do multiple
mucin genes respond to each bacterium similarly?
The increasing availability of mucin gene promoters
will facilitate studies of this kind.
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